Login:


Password:

Register | Lost Password

The Sino–Italian Heart and Brain...
MESPE Mission and Vision
MESPE's Adventures: MESPE's...
MESPE Journal special issue number THREE
MESPE Journal special issue number TWO
MESPE Journal special issue number ONE

HAT: After MI, no survival advantage to keeping an AED at home APRIL 1, 2008 | Steve Stiles

01) PLATO-Invasive in print, with new data on stent thrombosis for ticagrelor

02) PLATO shows benefits of ticagrelor over clopidogrel

03) Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

A) FDA panel recommends against approval of all indications for ximelagatran

A) RE-LY: Oral antithrombin dabigatran outshines warfarin in atrial fib AUGUST 30, 2009 | Steve Stiles

ARREST finds link between chest compressions and VF recurrence during CPR

ARREST finds link between chest compressions and VF recurrence during CPR

B) Dabigatran versus warfarin in patients with atrial fibrillation.

B) SPORTIF V, THRIVE, cost studies published: Is there life yet for ximelagatran?

C) Exanta withdrawn from market worldwide, further studies halted

C) Oral anticoagulant appears as effective as enoxaparin for surgery- related VTE prophylaxis

D) Ximelagatran remains as good as warfarin in combined SPORTIF analysis

E) Interventional cardiologists tackle COURAGE

F) Medical therapy takes COURAGE: No benefit of PCI over optimal drugs for preventing events in stable CAD

D) RE-NOVATE published: Dabigatran promising in VTE prevention

US Registry On ICD Complications HRS Boston 2009

Clinical Trials on VT Ablation 2009

ICD in Primary Prevention. ALTITUDE Study